Hugo Ten Cate Selected Research

Hemophilia A (Haemophilia)

8/2023	Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis.
12/2019	Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets.
12/2012	Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study.
3/2012	Thrombin generation in clinical conditions.
9/2008	Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hugo Ten Cate Research Topics

Disease

46	Thrombosis (Thrombus) 03/2024 - 12/2004
43	Hemorrhage 02/2024 - 09/2003
25	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024 - 07/2010
16	COVID-19 05/2024 - 08/2020
16	Inflammation (Inflammations) 05/2023 - 02/2004
15	Venous Thromboembolism 09/2023 - 11/2016
14	Atrial Fibrillation 09/2023 - 01/2016
12	Stroke (Strokes) 02/2024 - 12/2007
12	Neoplasms (Cancer) 12/2023 - 04/2011
11	Thrombophilia 01/2024 - 12/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 02/2010
9	Thrombocytopenia (Thrombopenia) 01/2024 - 09/2003
9	Atherosclerosis 01/2023 - 12/2004
8	Peripheral Arterial Disease 09/2022 - 03/2015
8	Disseminated Intravascular Coagulation 04/2021 - 09/2003
7	Pulmonary Embolism 12/2022 - 12/2014
6	Ischemic Stroke 05/2023 - 03/2015
5	Hemophilia A (Haemophilia) 08/2023 - 09/2008
5	Infections 02/2023 - 01/2020
5	Sepsis (Septicemia) 01/2023 - 01/2004
5	Vascular Diseases (Vascular Disease) 06/2022 - 03/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021 - 08/2013
5	Wounds and Injuries (Trauma) 01/2019 - 01/2013
4	Thromboembolism 12/2021 - 01/2012
4	Acute Coronary Syndrome 01/2019 - 02/2012
3	Disease Susceptibility (Diathesis) 08/2023 - 03/2012
3	Embolism (Embolus) 01/2022 - 10/2016
3	Obesity 02/2021 - 12/2019
3	Postthrombotic Syndrome 08/2020 - 07/2010
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 12/2004
3	Fibrosis (Cirrhosis) 01/2017 - 08/2008
3	Polycythemia Vera 09/2011 - 11/2008
3	Essential Thrombocythemia 09/2011 - 11/2008
2	Virus Diseases (Viral Diseases) 08/2023 - 01/2023
2	Thromboinflammation 05/2023 - 01/2023
2	Endotoxemia 01/2023 - 10/2008
2	Critical Illness (Critically Ill) 01/2023 - 01/2022
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2021 - 11/2020
2	Venous Insufficiency 10/2021 - 01/2018
2	Leukemia 04/2021 - 01/2018
2	Heart Failure 01/2021 - 07/2019
2	Lymphoma (Lymphomas) 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 12/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

40	AnticoagulantsIBA 02/2024 - 02/2004
35	Thrombin FDA Link 01/2024 - 09/2008
16	Biomarkers (Surrogate Marker)IBA 05/2023 - 06/2017
13	Hemostatics (Antihemorrhagics)IBA 08/2023 - 12/2012
12	FibrinIBA 08/2023 - 01/2004
11	Fibrinogen (Factor I)FDA Link 03/2024 - 12/2004
11	Vitamin K FDA Link 09/2023 - 06/2010
11	Blood Coagulation Factors (Coagulation Factor)IBA 06/2022 - 10/2011
9	fibrin fragment D (D-dimer)IBA 11/2022 - 12/2004
8	Heparin (Liquaemin)FDA LinkGeneric 08/2023 - 09/2003
7	Thromboplastin (Tissue Factor)IBA 12/2023 - 12/2004
7	Factor XIa (Coagulation Factor XIa)IBA 01/2023 - 01/2016
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 03/2015
6	RivaroxabanIBA 08/2022 - 01/2018
6	Dabigatran FDA Link 05/2020 - 12/2015
5	C-Reactive ProteinIBA 01/2024 - 12/2004
5	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 09/2003
5	Prothrombin (Factor II)IBA 12/2020 - 12/2012
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2023 - 01/2016
4	Adenosine Diphosphate (ADP)IBA 01/2023 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2017
4	EnzymesIBA 01/2022 - 01/2018
4	CollagenIBA 01/2022 - 03/2015
4	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 03/2014
4	idarucizumabIBA 05/2020 - 01/2017
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2023 - 05/2021
3	CoagulantsIBA 11/2023 - 12/2019
3	Warfarin (Coumadin)FDA LinkGeneric 09/2023 - 07/2018
3	Indicators and Reagents (Reagents)IBA 08/2023 - 09/2003
3	LipopolysaccharidesIBA 01/2023 - 03/2004
3	VaccinesIBA 01/2023 - 01/2022
3	von Willebrand FactorIBA 01/2023 - 06/2019
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 12/2004
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 05/2021 - 12/2014
3	estropipate (Ogen)FDA LinkGeneric 03/2021 - 03/2004
3	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2017
3	Factor Xa InhibitorsIBA 12/2020 - 07/2019
3	Clopidogrel (Plavix)FDA Link 01/2019 - 08/2011
3	ThrombomodulinIBA 03/2012 - 12/2004
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2024 - 08/2022
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 08/2023 - 08/2023
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 01/2012
2	AntigensIBA 10/2022 - 01/2020
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 02/2021 - 01/2017
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2018
2	Factor VIII (Coagulation Factor VIII)IBA 10/2020 - 09/2008
2	IntegrinsIBA 06/2019 - 03/2015

Therapy/Procedure

47	Therapeutics 05/2024 - 07/2010
6	Critical Care (Surgical Intensive Care) 08/2023 - 01/2020
6	Extracorporeal Membrane Oxygenation 11/2022 - 01/2020
5	Catheters 03/2024 - 01/2020
5	Compression Stockings 01/2022 - 07/2010
5	Percutaneous Coronary Intervention 05/2021 - 04/2010
4	Stents 01/2021 - 04/2010
3	Home Nursing (Nursing, Home) 05/2024 - 08/2020
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 09/2003
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2018